Treatment Stories
693 articles
Sharing My Knowledge With Others
David Dessert knew his family carried BRCA2, and told his doctor after his pancreatic cancer diagnosis. This led to a better treatment plan.
Let’s Win! Pancreatic Cancer Survivors Series—Year Four
Our inspiring Survivors video series is entering Year Four. Meet more long-term survivors as well as researchers working for new treatments.
Let’s Win! Pancreatic Cancer Survivors Series—Year Three
Let’s Win kicks off Year Three of its Survivors Series of videos. The 2020 videos will feature patients with genetic mutations and more researchers.
Find the Joy in Your Life Every Day
Long-term survivor Donna Robinson decided to focus on joy rather than fear during treatment for pancreatic cancer.
Let’s Win Pancreatic Cancer Survivors—Year Eight
Let’s Win introduces Year Eight of its long-term survivors video series, featuring women and men who were in all stages of the disease.
No One Fights Alone
Long-term survivor Michael Florio utilized his vast support network of family and friends to help in his battle against pancreatic cancer.
Living Longer with Pancreatic Neuroendocrine Tumors
Dr. Pamela Hodul walks us through different types of pancreatic neuroendocrine tumors (PNET) and how rare they are along with the latest treatment options.
Unraveling the Web for Reliable Pancreatic Cancer Information
Dr. Mark Lewis and journalist Steve Doig explain how to judge whether the information about pancreatic cancer on the internet is from a reliable source.
Prognosis: More Than Numbers in Pancreatic Cancer
What is pancreatic cancer prognosis? Dr. Joshua Lakin of Harvard explains how prognosis works, and ways to possibly defy the odds when facing a slow recovery.
Tumor Staging and Pancreatic Cancer
What is tumor staging and how does it affect treatment? Dr. Shubham Pant helps explain how pancreatic cancer tumors are staged and graded.
A New Chemotherapy and Radiation Regimen to Shrink Tumors Before Surgery
Researchers are testing a new combination of chemotherapies and radiation to shrink pancreatic cancer tumors and make surgical removal possible.
Targeting Tumor Proteins Specific to Pancreatic Cancer Cells
A clinical trial tests the safety and effectiveness of tumor-associated antigen-specific cytotoxic T lymphocytes, which target specific tumor proteins.
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.
Precision Medicine from the Get-Go for Pancreatic Cancer
Dr. Ben George and colleagues at the Medical College of Wisconsin are using molecular profiling to determine the best chemotherapy for a patient’s pancreatic cancer.